Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Revenue Expected To Reach $62.82 Billion By 2030
The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Is The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market’s Market Value Anticipated To Evolve From 2026 To 2030?
The chronic obstructive pulmonary disease (copd) and asthma devices market size has demonstrated significant growth in recent years. This market is projected to expand from $47.56 billion in 2025 to $50.3 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.8%. The historical growth can be attributed to the rising prevalence of asthma and COPD, increasing air pollution and smoking rates, the growing adoption of inhalation therapy, the expansion of respiratory care services, and improved diagnosis of chronic respiratory diseases.
The chronic obstructive pulmonary disease (copd) and asthma devices market is projected to experience robust expansion in the coming years, reaching a valuation of $62.83 billion by 2030, driven by a compound annual growth rate (CAGR) of 5.7%. This anticipated growth is primarily fueled by factors such as an aging demographic more susceptible to respiratory issues, an increasing need for in-home respiratory care equipment, enhanced recognition of the importance of early intervention in respiratory conditions, the broader implementation of chronic disease management initiatives, and improved availability of respiratory services in developing regions. Key developments anticipated during this forecast period encompass the increasing integration of respiratory care devices into home settings, a heightened preference for portable and convenient inhalation products, an intensified focus on comprehensive long-term disease management strategies, the broader application of these devices among both pediatric and elderly patient groups, and a reinforced commitment to ensuring treatment compliance and effective symptom management.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18298&type=smp
What Are The Main Drivers Accelerating The Growth Of The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
The increasing incidence of respiratory ailments is anticipated to drive the expansion of the chronic obstructive pulmonary disease (COPD) and asthma devices market going forward. These conditions encompass a broad spectrum of illnesses impacting the lungs and respiratory systems, such as asthma, chronic obstructive pulmonary disease, pneumonia, and lung cancer, thereby affecting breathing and overall respiratory function. The rising prevalence of respiratory diseases stems from escalating air pollution levels, evolving climate patterns influencing allergens and pathogens, and lifestyle habits like smoking, which compromise respiratory health. COPD and asthma devices are vital for the comprehensive management and treatment of respiratory diseases, helping patients achieve better respiratory health and improve their overall well-being. For instance, in December 2023, the National Center for Biotechnology Information, a US-based government agency, projected that the number of COPD cases would surge by 112 million, reaching a total of 592 million by 2050, representing 9.5% of the eligible population. Consequently, the growing prevalence of respiratory diseases propels the growth of the chronic obstructive pulmonary disease (COPD) and asthma devices markets.
What Segment Categories Are Evaluated In The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Study?
The chronic obstructive pulmonary disease (copd) and asthma devices market covered in this report is segmented –
1) By Type: Metered Dose Inhalers, Drug Powder Inhalers, Soft Mist Inhalers, Jet Nebulizers, Ultrasonic Nebulizers, Other Types
2) By Indication: Asthma, Chronic Obstructive Pulmonary Disease
3) By Application: Hospitals, Clinics, Home Care Settings, Research Institutions, Other Applications
4) By End User: Pediatric, Adult, Geriatric
Subsegments:
1) By Metered Dose Inhalers: Conventional MDI, Breath-Actuated MDI
2) By Drug Powder Inhalers: Dry Powder Inhalers (DPI), Multi-Dose DPI
3) By Soft Mist Inhalers: Respimat Soft Mist Inhalers, Other Soft Mist Devices
4) By Jet Nebulizers: Pneumatic Nebulizers, Venturi-Type Nebulizers
5) By Ultrasonic Nebulizers: Tabletop Ultrasonic Nebulizers, Portable Ultrasonic Nebulizers
6) By Other Types: Nebulizer Accessories, Spacer Devices
What Trends Are Influencing The Future Of The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
Major companies within the chronic obstructive pulmonary disease and asthma devices market are concentrating on developing innovative solutions, such as intelligent, sensor-equipped inhaler technologies. These advancements aim to improve medication adherence, enable real-time symptom tracking, and support personalized respiratory disease management. Smart inhaler technologies involve the integration of embedded sensors and digital connectivity features to gather inhalation data, monitor patient usage patterns, and provide actionable insights to both patients and healthcare providers. For instance, in July 2023, Teva UK Ltd., a pharmaceutical company based in the UK, launched the GoResp Digihaler. This digitally connected inhaler is designed to record inhalation parameters, offer immediate feedback, and support enhanced disease control through patient engagement driven by data. The device contributes to better treatment outcomes by enabling remote monitoring, giving clinicians more profound visibility into patient adherence trends, and strengthening long-term disease management for individuals living with chronic respiratory conditions.
Which Industry Players Are Present In The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
Major companies operating in the chronic obstructive pulmonary disease (copd) and asthma devices market are AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, Boehringer Ingelheim, Royal Philips NV, Teva Pharmaceuticals Industries Ltd., Omron Corporation, Smiths Medical Inc., Cipla Ltd., Chiesi Farmaceutici SpA, Sunovion Pharmaceuticals Inc., Drive DeVilbiss Healthcare, Pari Respiratory Equipment Inc., Allied Healthcare Products Inc., Clement Clarke International Ltd., Cohero Health Inc., Pneuma Respiratory Inc., Mundipharma International Ltd., 3M Health Care, Vyaire Medical Inc., Aerogen Ltd
Access The Complete Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Report:
Which Region Holds The Largest Share In The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
North America was the largest region in the chronic obstructive pulmonary disease (COPD) and asthma devices market in 2025. The regions covered in the chronic obstructive pulmonary disease (copd) and asthma devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=18298&type=smp
Browse Through More Reports Similar to the Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market 2026, By The Business Research Company
High Performance Liquid Chromatography Market Report 2026
Analytical Laboratory Instrument Market Report 2026
Chromatography Software Market Report 2026
https://www.thebusinessresearchcompany.com/report/chromatography-software-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model